186 related articles for article (PubMed ID: 28904188)
1. Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients.
Dai YC; Xia M; Huang Q; Tan M; Qin L; Zhuang YL; Long Y; Li JD; Jiang X; Zhang XF
J Clin Microbiol; 2017 Dec; 55(12):3366-3373. PubMed ID: 28904188
[TBL] [Abstract][Full Text] [Related]
2. Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera.
Dai YC; Zhang XF; Xia M; Tan M; Quigley C; Lei W; Fang H; Zhong W; Lee B; Pang X; Nie J; Jiang X
PLoS One; 2015; 10(4):e0124945. PubMed ID: 25915764
[TBL] [Abstract][Full Text] [Related]
3. Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.
Blazevic V; Malm M; Vesikari T
J Med Virol; 2015 Oct; 87(10):1656-61. PubMed ID: 25946711
[TBL] [Abstract][Full Text] [Related]
4. Genotype distribution of norovirus around the emergence of Sydney_2012 and the antigenic drift of contemporary GII.4 epidemic strains.
Zhang J; Shen Z; Zhu Z; Zhang W; Chen H; Qian F; Chen H; Wang G; Wang M; Hu Y; Yuan Z
J Clin Virol; 2015 Nov; 72():95-101. PubMed ID: 26476326
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China.
Zhang XF; Chen JR; Song CL; Xie DJ; Tan M; Wang L; Koroma MM; Hou YZ; Dong ZP; Yu JR; Duan WT; Zhao DD; Du JR; Zhu L; Dai YC
Epidemiol Infect; 2020 Dec; 148():e289. PubMed ID: 33292874
[TBL] [Abstract][Full Text] [Related]
6. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
Koromyslova AD; Morozov VA; Hefele L; Hansman GS
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
[TBL] [Abstract][Full Text] [Related]
7. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
[TBL] [Abstract][Full Text] [Related]
8. Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.
Carmona-Vicente N; Fernández-Jiménez M; Ribes JM; Téllez-Castillo CJ; Khodayar-Pardo P; Rodríguez-Diaz J; Buesa J
J Med Virol; 2015 Apr; 87(4):675-82. PubMed ID: 25655810
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China.
Jin M; Zhou YK; Xie HP; Fu JG; He YQ; Zhang S; Jing HB; Kong XY; Sun XM; Li HY; Zhang Q; Li K; Zhang YJ; Zhou DQ; Xing WJ; Liao QH; Liu N; Yu HJ; Jiang X; Tan M; Duan ZJ
J Gen Virol; 2016 Oct; 97(10):2620-2632. PubMed ID: 27543110
[TBL] [Abstract][Full Text] [Related]
10. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
[TBL] [Abstract][Full Text] [Related]
12. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
[TBL] [Abstract][Full Text] [Related]
13. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
Malm M; Tamminen K; Vesikari T; Blazevic V
Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
[TBL] [Abstract][Full Text] [Related]
14. Genetic Analysis of Reemerging GII.P16-GII.2 Noroviruses in 2016-2017 in China.
Ao Y; Cong X; Jin M; Sun X; Wei X; Wang J; Zhang Q; Song J; Yu J; Cui J; Qi J; Tan M; Duan Z
J Infect Dis; 2018 Jun; 218(1):133-143. PubMed ID: 29617875
[TBL] [Abstract][Full Text] [Related]
15. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.
Cannon JL; Lindesmith LC; Donaldson EF; Saxe L; Baric RS; Vinjé J
J Virol; 2009 Jun; 83(11):5363-74. PubMed ID: 19297483
[TBL] [Abstract][Full Text] [Related]
16. Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010.
Takanashi S; Wang Q; Chen N; Shen Q; Jung K; Zhang Z; Yokoyama M; Lindesmith LC; Baric RS; Saif LJ
J Clin Microbiol; 2011 Sep; 49(9):3234-44. PubMed ID: 21752978
[TBL] [Abstract][Full Text] [Related]
17. Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.
Swanstrom J; Lindesmith LC; Donaldson EF; Yount B; Baric RS
J Virol; 2014 Jan; 88(2):829-37. PubMed ID: 24173225
[TBL] [Abstract][Full Text] [Related]
18. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
[TBL] [Abstract][Full Text] [Related]
19. Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019.
Tohma K; Landivar M; Ford-Siltz LA; Pilewski KA; Kendra JA; Niendorf S; Parra GI
Emerg Infect Dis; 2024 May; 30(5):1026-1029. PubMed ID: 38666659
[TBL] [Abstract][Full Text] [Related]
20. The endemic GII.4 norovirus-like-particle induced-antibody lacks of cross-reactivity against the epidemic GII.17 strain.
Du J; Gu Q; Liu Y; Li Q; Guo T; Liu Y
J Med Virol; 2021 Jun; 93(6):3974-3979. PubMed ID: 32869863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
